BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31539123)

  • 1. Overexpression of long noncoding RNA HOXC13-AS and its prognostic significance in hepatocellular carcinoma.
    Zhou JF; Shi YT; Wang HG; Yang XZ; Wu SN
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7369-7374. PubMed ID: 31539123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
    Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
    Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of long non-coding RNA MINCR contributes to progressive clinicopathological features and poor prognosis of human hepatocellular carcinoma.
    Jin XL; Lian JR; Guan YH
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8197-8202. PubMed ID: 30556858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma.
    Fu C; Xu X; Lu W; Nie L; Yin T; Wu D
    Medicine (Baltimore); 2019 Oct; 98(42):e17412. PubMed ID: 31626095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.
    Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J
    Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
    Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
    World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA RUSC1-AS-N indicates poor prognosis and increases cell viability in hepatocellular carcinoma.
    Tang R; Wu JC; Zheng LM; Li ZR; Zhou KL; Zhang ZS; Xu DF; Chen C
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):388-396. PubMed ID: 29424895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma.
    Zhang T; Cao C; Wu D; Liu L
    Tumour Biol; 2016 Feb; 37(2):2379-85. PubMed ID: 26373735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance.
    Ma HX; Shu QH; Pan JJ; Liu D; Xu GL; Li JS; Ma JL; Jia WD; Yv JH; Ge YS
    Tumour Biol; 2015 Jun; 36(6):4235-41. PubMed ID: 25592379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long non-coding RNA AK001796 contributes to poor prognosis and tumor progression in hepatocellular carcinoma.
    Han QL; Chen BT; Zhang KJ; Xia ST; Zhong WW; Zhao ZM
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2013-2019. PubMed ID: 30915744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of Long Non-Coding RNA ENST00000429227.1 Is Correlated with Poor Prognosis in Human Hepatocellular Carcinoma.
    Zhao Y; Kong CQ; Ye JZ; Bai T; Luo T; Wang D; Chen M; Wang HF; Wang XB; Liu JJ; Chen J; Luo HL; Li LQ
    Med Sci Monit; 2019 Aug; 25():6539-6546. PubMed ID: 31472071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of lncRNA TCONS_00027978 in hepatocellular carcinoma and its influence on prognosis and survival.
    Chen Q; Tian GD; Wang CC
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5655-5660. PubMed ID: 29271999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.
    Zheng ZK; Pang C; Yang Y; Duan Q; Zhang J; Liu WC
    J Int Med Res; 2018 Jan; 46(1):348-356. PubMed ID: 28856933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of a novel lncRNA
    Cui W; Huang J; Wang R; Wang Y; Chen X; Li J; Xu R
    Biomark Med; 2021 Oct; 15(14):1277-1288. PubMed ID: 34486883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.